Shine Pharmaceuticals Limited - Company Profile

It is a pharma public limited company based in Vadodara, Gujarat, India, established in 1994.
1994 Vadodara, Gujarat, India Active
Last Updated:
Access Report
About Shine Pharmaceuticals Limited

Shine Pharmaceuticals Limited, a active public limited company, was established on 17 August 1994 in Vadodara, Gujarat, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231GJ1994PLC022787. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹3.38 Cr.

Formerly known as Shine Pharmaceuticals Private Limited. It upholds a compliant status. Employing 780 professional, Its leadership includes Tejal Ashish Parikh (Director), Hiranmay Saha (Director), Samir Chakraborty (Managing Director). Past directors included Tejal Ashish Parikh, Noel Bhattacharjee, Rangoli Saurav Gada. It holds ₹0.68 M open charges and ₹9.30 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 309-310, Dwarkesh Complex, 3Rd Floor, Sun Pharma Road, Off. Old Padra Road, At, Ladara,, Vadodara, Gujarat, 390012.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231GJ1994PLC022787

  • Registration Number

    022787

  • Incorporation Date

    17 August 1994

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹3.38 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 3.38 Cr
  • Company Age 31 Year, 6 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 0.68 M
  • Satisfied Charges ₹ 9.30 Cr
  • Revenue Growth **** -5.27%
  • Profit Growth **** 46.63%
  • Ebitda **** -15.54%
  • Net Worth 22.51%
  • Total Assets **** 20.10%
Company report

Shine Pharmaceuticals Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Shine Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Shine Pharmaceuticals Limited?
Current Directors
Name Designation Appointment Date Status
Tejal Ashish Parikh Director 30 Mar 2024 Current
Hiranmay Saha Director 30 May 1996 Current
Samir Chakraborty Managing Director 01 Apr 2005 Current
Rangoli Saurav Gada Director 25 Mar 2023 Current
Aloka Saha Whole-Time Director 30 May 1996 Current
Pradeep Vishambhar Agrawal Whole-Time Director 01 Jul 2003 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Additional Director 29 Sep 2024 Past
Pramod Abcsdd Whole-Time Director 21 Sep 2019 Past
Pramod Abcsdd Additional Director 29 Sep 2023 Past
Pramod Abcsdd Director 01 Apr 2008 Past
Pramod Abcsdd Director 01 Apr 2008 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Shine Pharmaceuticals.

Shine Pharmaceuticals Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 5.27% decrease. The company also saw a substantial improvement in profitability, with a 46.63% increase in profit. The company's net worth Soared by an impressive increase of 22.51%.

Shine Pharmaceuticals revenue growth over time
Shine Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -5.27%
*******
*******
*******
*******
Revenue from Operations
*******
 -13.37%
*******
*******
*******
*******
Total Assets
*******
 20.10%
*******
*******
*******
*******
Profit or Loss
*******
 46.63%
*******
*******
*******
*******
Net Worth
*******
 22.51%
*******
*******
*******
*******
EBITDA
*******
 -15.54%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Shine Pharmaceuticals?

In 2024, Shine Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹680,000.00

Satisfied Charges

₹92,988,000.00

Charges Breakdown by Lending Institutions
  • Axis Bank Limited : 0.07 Cr
Latest Charge Details
Date Lender Amount Status
29 Jun 2019 Axis Bank Limited ₹0.68 M Open
24 Dec 2020 Others ₹2.00 Cr Satisfied
26 Sep 2019 Others ₹7.50 M Satisfied
03 Jan 2004 Bank Of Baroda ₹3.55 Cr Satisfied
05 Jul 2003 Bank Of Baroda ₹3.00 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Shine Pharmaceuticals?

Shine Pharmaceuticals has a workforce of 780 employees as of Mar 26, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Shine Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shine Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Shine Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Shine Pharmaceuticals Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Shine Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    Tejal Ashish Parikh was appointed as a Director was appointed as a Director on 30 Mar 2024 & has been associated with this company since 1 year 11 months . was recorded as a recent event.

  • Charges

    The activity A charge registered on 24 Dec 2020 via Charge ID 100397788 with Others was fully satisfied on 21 Mar 2024. was completed.

  • Director Appointment

    The activity Rangoli Saurav Gada was appointed as a Director was appointed as a Director on 25 Mar 2023 & has been associated with this company since 2 years 11 months . was completed.

  • Charges

    The activity A charge registered on 26 Sep 2019 via Charge ID 100294266 with Others was fully satisfied on 30 Mar 2022. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Shine Pharmaceuticals Limited?

The CIN of Shine Pharmaceuticals Limited is U24231GJ1994PLC022787.

Where is Shine Pharmaceuticals Limited headquartered?

Shine Pharmaceuticals Limited is headquartered at 309-310, Dwarkesh Complex, 3Rd Floor, Sun Pharma Road, Off. Old Padra Road, At, Ladara,, Vadodara, Gujarat, 390012.

When was Shine Pharmaceuticals Limited incorporated?

Shine Pharmaceuticals Limited was incorporated on 17 August 1994.

Who are the current directors of Shine Pharmaceuticals Limited?

The current directors of Shine Pharmaceuticals Limited are

What is the primary industry of Shine Pharmaceuticals Limited?

The primary industry of Shine Pharmaceuticals Limited is Manufacturing.

Is Shine Pharmaceuticals Limited a listed company?

Shine Pharmaceuticals Limited is unlisted.

What is the capital structure of Shine Pharmaceuticals Limited?

The authorized capital of Shine Pharmaceuticals Limited is ₹5.00 Cr, and the paid-up capital is ₹3.38 Cr.

What is the compliance status of Shine Pharmaceuticals Limited?

The compliance status of Shine Pharmaceuticals Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available